Twitter | Search | |
patty spears
Cancer Research Patient Advocate
2,054
Tweets
374
Following
590
Followers
Tweets
patty spears retweeted
SABCS Oct 18
SABCS® is honored to announce Ann Partridge, MD, MPH of Dana-Farber Cancer Institute in Boston as the recipient of the 2018 AACR Outstanding Investigator Award for Breast Cancer Research. Congrats to Dr. Partridge on this esteemed award!
Reply Retweet Like
patty spears retweeted
FasterCures Oct 18
“Master protocols” are defined as protocols designed to answer multiple questions within the same overall trial structure. These efforts are being heralded as the pathway to less costly & more efficient clinical trials – but what about their challenges?
Reply Retweet Like
patty spears retweeted
Count Me In Oct 18
We are proud to announce the launch of Count Me In, a nonprofit that brings together patients & researchers as partners to accelerate discoveries in cancer research. Learn more at , , ,
Reply Retweet Like
patty spears retweeted
You Can Vote Oct 17
1/ Do you know that 31 races were decided by ONE VOTE in NC in 2015? Do you know what the amendment means for young people, those with low incomes, people with disabilities and seniors? Find out here!
Reply Retweet Like
patty spears retweeted
NCI CTEP Clinical Research Oct 15
just released a Request for Information on provisions for a possible new NIH data sharing policy. Visit for more information, including a link to the proposed provisions. Comments accepted until December 10!
Reply Retweet Like
patty spears Oct 16
Nice to hear discussion about how to present changes in PROs back to patients in a way they understand the meaning of the information.... Keeping ALL patients in mind.. an area that needs Research!
Reply Retweet Like
patty spears Oct 16
Good discussions by the panel...can’t necessarily repurpose adult questions/PROs in children...sometimes very different questions are needed... need to ask in the right way...... Sometimes it’s hard but always necessary to bring in the
Reply Retweet Like
patty spears Oct 16
Looks like a great topic to start the second day discussing
Reply Retweet Like
patty spears retweeted
MetastaticBCNetwork Oct 15
Understandably, most people are familiar with early stage breast cancer... Shirley Mertz came up with this table to help people understand the differences
Reply Retweet Like
patty spears Oct 15
Papadopoulos: Should you use an existing COA, modify an existing COA or develop a new COA? COAs need to be selected thoughtfully to fully assess the true patient experience.
Reply Retweet Like
patty spears Oct 15
Papadopoulos: The purpose of clinical outcome assessments.
Reply Retweet Like
patty spears retweeted
Jen Hoverstad Oct 15
The immunotherapy lab at is working to find ways that the immune system will attack . It’s looking at a variety of underlying issues, including dormant cancer cells involved in .
Reply Retweet Like
patty spears retweeted
Komen NCTC Oct 15
Metativor advocates at the federal level for more funding for research and increasing that funding for statistic breast cancer -Rhonda Howell
Reply Retweet Like
patty spears retweeted
Komen NCTC Oct 15
We need to make clinical trials easier for participation to be able to improve targeting for endocrine therapies to fight metastatic Dr Sarah Sammons
Reply Retweet Like
patty spears retweeted
Jen Hoverstad Oct 15
During awareness month, it’s important we talk about - over 150,000 women are battling it every day. Thanks to for bringing together today’s conversation.
Reply Retweet Like
patty spears retweeted
Jen Hoverstad Oct 15
In order to get a drug to market, it can take 15 years. This timeline is and that’s why these young researchers like Carey Anders are
Reply Retweet Like
patty spears Oct 15
Patient Experience Data... not only different patients have different experiences... one patient has different experiences over the course of their disease. Arnedo
Reply Retweet Like
patty spears Oct 15
Reply Retweet Like
patty spears retweeted
antony ruggeri Oct 14
Quick reminder. BRCA 1/2 carriers 55-75% lifetime risk of breast cancer. But ovarian cancer risk is different BRCA1. About 40% BRCA 2 about 15% Claudine Isaacs
Reply Retweet Like
patty spears retweeted
Komen NCTC Oct 13
We support those living with on and every day. MBC is and we look forward to hearing from patients, researchers, & clinicians at our Young Researchers Breakfast on October 15th
Reply Retweet Like